New Diagnostic Tools Aim to Improve Detection of Canine Mast Cell Tumors
Mast cell tumors remain one of the most frequently diagnosed cancers in dogs—and one of the most challenging to identify early. Often appearing as ordinary skin masses, they can be difficult to distinguish from benign lesions without further testing, which can delay diagnosis and treatment decisions.
Zoetis, IDEXX, and Weave Report Strong Q2 2024 Earnings, Announce Growth Strategies
The veterinary and healthcare sectors saw significant activity this quarter as Zoetis, IDEXX Laboratories, and Weave all reported robust financial results, underscoring their continued growth and strategic advancements.
IDEXX's Record-Breaking Year: Surging Growth and Revolutionary Pet Healthcare Innovations
For the fourth quarter of 2023, IDEXX's revenues soared to $902 million, marking a robust 9% increase from the previous year on a reported basis and 8% on an organic basis. This growth was primarily driven by the Companion Animal Group ("CAG"), which saw a 10% rise in reported revenue and a 9% increase organically. The CAG Diagnostics segment, in particular, experienced an impressive 11% growth in recurring revenue on a reported basis and 10% organically, underlining the company’s strong market presence and innovative approach.